These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 23629723

  • 1. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
    McEvoy CR, Tsuji B, Gao W, Seemann T, Porter JL, Doig K, Ngo D, Howden BP, Stinear TP.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3240-9. PubMed ID: 23629723
    [Abstract] [Full Text] [Related]

  • 2. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, Robins-Browne R, Davies JK, Seemann T, Stinear TP.
    PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
    [Abstract] [Full Text] [Related]

  • 3. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
    Yin Y, Chen H, Li S, Gao H, Sun S, Li H, Wang R, Jin L, Liu Y, Wang H.
    Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
    [Abstract] [Full Text] [Related]

  • 4. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
    Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di Pietro C, Purrello M, Stefani S.
    PLoS One; 2012 Dec; 7(1):e29573. PubMed ID: 22253738
    [Abstract] [Full Text] [Related]

  • 5. Influence of IS256 on Genome Variability and Formation of Small-Colony Variants in Staphylococcus aureus.
    Kleinert F, Kallies R, Hort M, Zweynert A, Szekat C, Nagel M, Bierbaum G.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584147
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
    Rose WE, Fallon M, Moran JJ, Vanderloo JP.
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502
    [Abstract] [Full Text] [Related]

  • 7. IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate.
    Kuroda M, Sekizuka T, Matsui H, Ohsuga J, Ohshima T, Hanaki H.
    Front Microbiol; 2019 Aug; 10():1882. PubMed ID: 31474962
    [Abstract] [Full Text] [Related]

  • 8. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
    Rao Y, Peng H, Shang W, Hu Z, Yang Y, Tan L, Li M, Zhou R, Rao X.
    J Adv Res; 2022 Sep; 40():167-178. PubMed ID: 36100324
    [Abstract] [Full Text] [Related]

  • 9. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
    Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K.
    Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
    [Abstract] [Full Text] [Related]

  • 10. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
    Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M.
    Infect Genet Evol; 2016 Sep; 43():197-202. PubMed ID: 27154328
    [Abstract] [Full Text] [Related]

  • 11. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 12. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato'o Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang Y, Cui L.
    Sci Rep; 2020 Sep 30; 10(1):16107. PubMed ID: 32999359
    [Abstract] [Full Text] [Related]

  • 13. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.
    Vidaillac C, Gardete S, Tewhey R, Sakoulas G, Kaatz GW, Rose WE, Tomasz A, Rybak MJ.
    J Infect Dis; 2013 Jul 30; 208(1):67-74. PubMed ID: 23539745
    [Abstract] [Full Text] [Related]

  • 14. Investigating the effect of an identified mutation within a critical site of PAS domain of WalK protein in a vancomycin-intermediate resistant Staphylococcus aureus by computational approaches.
    Baseri N, Najar-Peerayeh S, Bakhshi B.
    BMC Microbiol; 2021 Sep 02; 21(1):240. PubMed ID: 34474665
    [Abstract] [Full Text] [Related]

  • 15. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
    Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A.
    PLoS Pathog; 2012 Feb 02; 8(2):e1002505. PubMed ID: 22319446
    [Abstract] [Full Text] [Related]

  • 16. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
    Passalacqua KD, Satola SW, Crispell EK, Read TD.
    Antimicrob Agents Chemother; 2012 Oct 02; 56(10):5212-23. PubMed ID: 22850507
    [Abstract] [Full Text] [Related]

  • 17. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.
    Baseri N, Najar-Peerayeh S, Bakhshi B.
    Infect Genet Evol; 2021 Jan 02; 87():104628. PubMed ID: 33171303
    [Abstract] [Full Text] [Related]

  • 18. Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus.
    Werth BJ, Ashford NK, Penewit K, Waalkes A, Holmes EA, Ross DH, Shen T, Hines KM, Salipante SJ, Xu L.
    Clin Microbiol Infect; 2021 Jun 02; 27(6):910.e1-910.e8. PubMed ID: 32866650
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.
    Park C, Shin NY, Byun JH, Shin HH, Kwon EY, Choi SM, Kim SH, Kwon JC, Park SH, Choi JH, Yoo JH, Yoo JI, Chung GT, Lee DG.
    J Med Microbiol; 2012 Mar 02; 61(Pt 3):345-352. PubMed ID: 22016559
    [Abstract] [Full Text] [Related]

  • 20. A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.
    Zhu J, Liu B, Shu X, Sun B.
    Int J Med Microbiol; 2021 Feb 02; 311(2):151473. PubMed ID: 33445057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.